We are pleased to announce our participation in the 1st Annual European Neuroscience Innovation Forum, taking place in Zurich from March 3 to 5, 2026. During the event, we will be pitching CLM001, our breakthrough nanodrug targeting the root causes…
🌟We’re getting ready for BioFIT 2025 ! We’re delighted to announce CURLIM’s participation in BioFIT 2025, taking place in Strasbourg on December 2–3. And we are also proud to share that we have been selected to pitch in the “Rare…
We’re excited to announce that CURLIM will be attending BIO-Europe in Vienna — November 3–5, 2025! Following our recent Orphan Drug Designation (EU) and our recognition by the French government for innovative research (I-Lab award-winning project), we are proud to…
We’re thrilled to announce that CURLIM will be participating in BioEquity Europe 2025 as a presenting company! This prestigious event is a key gathering for biotech leaders, investors, and innovators shaping the future of healthcare. The 2025 edition will take place from…